Financial Ratios

ZYDEN GENTEC LTD.

NSE : NABSE : 530091ISIN CODE : INE622B01045Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.870 (0 %)
PREV CLOSE ( ) 0.87
OPEN PRICE ( ) 0.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12355
TODAY'S LOW / HIGH ( )0.87 0.95
52 WK LOW / HIGH ( ) 0.870.95
NSE
This Company is not listed in NSE
Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.68-0.390.00-0.07-0.01
   CEPS(Rs)-0.68-0.390.00-0.07-0.01
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.081.762.152.152.22
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-37.71-322.09-24.22-345.44-102.75
   EBIT Margin(%)-329.29-76.00-24.22-102.62-2.08
   Pre Tax Margin(%)-329.30-294.26-24.58-103.73-10.89
   PAT Margin (%)-329.30-294.26-24.58-103.73-10.89
   Cash Profit Margin (%)-329.30-294.26-24.58-103.73-10.89
Performance Ratios
   ROA(%)-32.82-12.27-0.06-1.65-0.17
   ROE(%)-47.91-20.13-0.11-3.04-0.34
   ROCE(%)-33.84-3.36-0.07-1.75-0.04
   Asset Turnover(x)0.100.040.000.020.02
   Sales/Fixed Asset(x)16.750.210.010.040.04
   Working Capital/Sales(x)-0.81-12.98-0.01-0.080.09
Efficiency Ratios
   Fixed Capital/Sales(x)0.064.80131.4423.9726.27
   Receivable days803.052053.770.004076.654222.65
   Inventory Days0.00340.504700.43709.99664.39
   Payable days17.29542.687010.291593.45
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.00-13.09-142.17
   Price/Book(x)0.000.000.000.400.48
   Yield(%)0.000.00
   EV/Net Sales(x)11.4621.04340.8035.5245.30
   EV/Core EBITDA(x)-30.44-30.58-1407.22-34.61-1935.29
   EV/EBIT(x)-3.48-27.69-1407.22-34.61-1935.29
   EV/CE(x)1.611.050.880.600.65
   M Cap / Sales0.000.000.0013.5817.40
Growth Ratio
   Net Sales Growth(%)54.291280.45-84.905.14-78.75
   Core EBITDA Growth(%)15.64-3822.7096.44-4509.46-147.30
   EBIT Growth(%)-568.52-4231.8496.44-4509.4696.57
   PAT Growth(%)-72.660.0096.42-791.1384.37
   EPS Growth(%)-72.660.0096.42-791.1396.87
Financial Stability Ratios
   Total Debt/Equity(x)0.340.470.610.660.78
   Current Ratio(x)0.340.990.550.511.36
   Quick Ratio(x)0.340.850.470.431.30
   Interest Cover(x)0.00-0.35-67.53-92.77-0.24
   Total Debt/Mcap(x)1.621.63

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.